PDL BioPharma, Inc. (PDLI) Misses Q1 EPS by 1c
Get Alerts PDLI Hot Sheet
Join SI Premium – FREE
PDL BioPharma, Inc. (NASDAQ: PDLI) reported Q1 EPS of $0.44, $0.01 worse than the analyst estimate of $0.45. Revenue for the quarter came in at $139.7 million versus the consensus estimate of $130.93 million.
For earnings history and earnings-related data on PDL BioPharma, Inc. (PDLI) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Midday movers: Meta, IBM, Caterpillar fall; Chipotle rises
- Airbus revenue rises, delivers 142 commercial aircraft in Q1
- TechnipFMC (FTI) PT Raised to $30 at BTIG
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!